Biotech news, latest stories & analysis

Find today's trending Biotech news & headlines

NeoGenomics stock surged but technicals point to a pullback
  • NeoGenomics share price surged hard after strong results.
  • The company expects its annual revenue will be between $650M and $660M this year.
  • It is also narrowing its cash burn and working to monetize its pharma business.
February 22, 2024

Trading ideas & analysis

Is Altimmune (ALT) stock a good buy after the 306% jump?
December 8, 2023

EyePoint (EYPT) stock price went parabolic: brace for a pullback
December 5, 2023
Fusion Antibodies (FAB) shares surged but gains could be brief
November 29, 2023

More breaking stories